INDV
Indivior Pharmaceuticals Inc · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26
Figures on this page computed 2026-11-08 12:32 UTC
Last close
36.28USD
Market data, 2026-11-02
Weekly closes, 2025-11-07 to 2026-11-02
Over that span: +15.8%
Except where said otherwise: 10-K for 2025, filed 2026-02-26
21.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
396.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
16.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
-7.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
n/aDividend yield
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- Computed from the filing for 2016
Safety is the furthest below its sector's middle: 0.44 against 0.53 on the market's range.
- Growth13.9%82 of 100, above its sector
- Returns on capital396.9%98 of 100, above its sector
- Margins80.2%72 of 100, above its sector
- Price21.6x37 of 100, above its sector
- Safety0.7144 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aThe stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-26
- Sales1.27x
Its own average over 10 years, 972.1M.
- Profit3.53x
Its own average over 10 years, 59.6M.
- Free cash flow-1.24x
Its own average over 10 years, 74.9M.
- Debt1.01x
Its own average over 9 years, 347.9M.
- Price2.14x
Its own average over 11 years, 17. Market data, 2026-11-02
Profit is furthest from its own average, at 3.53 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | n/a |
| 2017-12-31 | 118.5 | 190.1 | n/a |
| 2018-12-31 | 99.1 | 819.5 | n/a |
| 2019-12-31 | 81.0 | 418.1 | n/a |
| 2020-12-31 | 66.8 | -461.8 | n/a |
| 2021-12-31 | 81.6 | 639.6 | n/a |
| 2022-12-31 | 93.0 | -131.0 | 100.0 |
| 2023-12-31 | 112.8 | -393.1 | 98.6 |
| 2024-12-31 | 122.6 | 21.8 | 95.7 |
| 2025-12-31 | 127.9 | 655.2 | 92.1 |
How sales was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
Figures behind the shape
Growth
13.9%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate13.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income2900.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
396.9%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital396.9%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
Return on equityn/mnegative equity
Negative equity.
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
Return on assets17.5%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
Margins
80.2%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin80.2%
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Operating margin21.1%
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Net margin16.9%
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Free cash flow margin-7.5%
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Price
21.6xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings21.6x
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
Price to bookn/a10-Q for 2025, filed 2026-10-29
We do not hold this figure for this company, so there is nothing to place.
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-068013
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-10-29
- computed
- 10-K for 2025, filed 2026-02-26
EV to EBITDA17.6x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-26
Price to sales ratio3.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Safety
0.71safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
Current ratio0.7110-Q for 2025, filed 2026-10-29
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-068013
- Reported in
- USD
- 10-Q for 2025, filed 2026-10-29
- 10-Q for 2025, filed 2026-10-29
Interest coverage5.8x
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Altman Z-Score3.35
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
What it pays out
n/aThe stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- Computed from the filing for 2016
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- Computed from the 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.